BlackRock
CASM

BlackRock’s CAS Medical Systems, Inc. CASM Stock Holding History

BlackRock’s Portfolio CASM Stock Details CASM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-84,279
Closed -$205K – 5175
2019
Q1 		$205K Sell
84,279
-3,669
-4% -$7.89K ﹤0.01% 4235
2018
Q4 		$140K Buy
87,948
+407
+0.5% +$758 ﹤0.01% 4293
2018
Q3 		$199K Buy
87,541
+3,450
+4% +$7.36K ﹤0.01% 4316
2018
Q2 		$164K Buy
84,091
+71,525
+569% +$107K ﹤0.01% 4362
2018
Q1 		$16K Buy
12,566
+504
+4% +$568 ﹤0.01% 4598
2017
Q4 		$9K Buy
12,062
+708
+6% +$518 ﹤0.01% 4656
2017
Q3 		$10K Buy
11,354
+1,197
+12% +$1.23K ﹤0.01% 4683
2017
Q2 		$12K Sell
10,157
-95,571
-90% -$109K ﹤0.01% 4714
2017
Q1 		$153K Buy
+105,728
New +$161K ﹤0.01% 4268

BlackRock's CASM Position: Q2 2019 in Review

BlackRock sold out of CAS Medical Systems, Inc. (CASM) in Q2 2019, closing a stake of 84,279 shares — an estimated $205K sold.

BlackRock first reported a position in CASM in Q1 2017 and held it in 9 quarters. The position peaked at $205K in Q1 2019. 0 funds tracked by Wall St. Rank hold CASM as of Q2 2019.

  • BlackRock reported no remaining CAS Medical Systems, Inc. position as of Q2 2019 after selling out during the quarter.
  • BlackRock sold 84,279 CAS Medical Systems, Inc. shares in Q2 2019, an estimated $205K.
  • BlackRock first reported a position in CAS Medical Systems, Inc. in Q1 2017 and held it in 9 quarters.
  • BlackRock's CAS Medical Systems, Inc. position peaked at $205K in Q1 2019.
  • 0 funds tracked by Wall St. Rank held CAS Medical Systems, Inc. as of Q2 2019.

Based on BlackRock's 13F filing for Q2 2019, filed 13 Aug 2019.